Prostatis Group LLC QRFT β€” EXCHANGE LISTED FDS TR

Ownership history in Prostatis Group LLC  Β·  4 quarters on record

AI Ownership Summary

Prostatis Group LLC reported EXCHANGE LISTED FDS TR (QRFT) in 4 quarterly 13F filings from 2025 Q1 through 2025 Q4. Peak portfolio weight reached 3.72% in 2025 Q1. The latest visible filing shows QRFT at 2.24% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this QRFT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Prostatis Group LLC's position in EXCHANGE LISTED FDS TR, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

QRFT was reported at 2.24% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
3.72% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

QRFT stock page Prostatis Group LLC fund profile Prostatis Group LLC full holdings
How Prostatis Group LLC held QRFT β€” position size vs. price
% of Fund (quarterly)    QRFT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED β€” β€” β€” 150,345 +34,299 +29.6% 2.24% $9.4M 2026-02-14 (Est.) $61.99
2025 Q3 ADDED β€” β€” β€” 116,046 +3,403 +3.0% 1.77% $7.1M 2025-11-04 $61.67
2025 Q2 REDUCED 51.1% +6.8% ❌ 112,643 -117,854 -51.1% 1.83% $6.4M 2025-07-25 $58.11
2025 Q1 INITIATED β€” β€” β€” 230,497 β€” β€” 3.72% $11.8M 2025-05-16 $54.27

🏒 Other funds also holding QRFT

As of 2026 Q1 β€” sorted by position size

UBS Group AG 3Y 7Y 0.0%

FAQ About Prostatis Group LLC and QRFT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Prostatis Group LLC reported owning QRFT?

Prostatis Group LLC reported QRFT across 4 quarterly 13F filings, from 2025 Q1 through 2025 Q4.

What was the largest reported QRFT position in Prostatis Group LLC's portfolio?

The largest reported portfolio weight for QRFT was 3.72% in 2025 Q1.

What is the latest reported QRFT position on this page?

The most recent filing on this page is 2025 Q4, when Prostatis Group LLC reported 150,345 shares, equal to 2.24% of portfolio, with an estimated market value of $9.4M.

What does the chart on this QRFT ownership page compare?

The chart compares Prostatis Group LLC's quarterly QRFT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Prostatis Group LLC time their QRFT position?

Based on 13F filing dates vs. subsequent QRFT price moves, Prostatis Group LLC correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on QRFT relative to SPY over the holding period was -1.7%.

← Back to Prostatis Group LLC Holdings